trending Market Intelligence /marketintelligence/en/news-insights/trending/0cBjnB0z1eCGAXypHhnLTw2 content esgSubNav
In This List

Hangzhou Just Biotherapeutics closes $57M financing


Banking Essentials Newsletter: 7th February Edition

Case Study

A Bank Outsources Data Gathering to Meet Basel III Regulations


Private Markets 360° | Episode 8: Powering the Global Private Markets (with Adam Kansler of S&P Global Market Intelligence)


Banks’ Response to Rising Rates & Liquidity Concerns

Hangzhou Just Biotherapeutics closes $57M financing

Hangzhou Just Biotherapeutics Ltd. closed a $57 million series B financing led by Temasek Holdings (Pte) Ltd. (Unspecified Vehicle) and existing investors Lilly Asia Ventures and ARCH Venture Partners LLC.

New investors in the round included Taikang, Hangzhou Economic & Technological Development Area, Bank of China and Bank of Hangzhou.

The funds will be used to advance the company's product pipeline and to complete a research and manufacturing facility in China.